Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14101 | 792 | 40.6 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
14101 | 1 | IDIOTYPE//IDIOTYPE VACCINATION//IDIOTYPE VACCINE | 792 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IDIOTYPE | authKW | 1182711 | 12% | 33% | 94 |
2 | IDIOTYPE VACCINATION | authKW | 209898 | 1% | 78% | 7 |
3 | IDIOTYPE VACCINE | authKW | 183687 | 1% | 53% | 9 |
4 | CELL THER Y AREA | address | 137678 | 1% | 36% | 10 |
5 | UNIV NAVARRA HOSP | address | 115660 | 0% | 100% | 3 |
6 | RELAY HYPOTHESIS | authKW | 107088 | 1% | 56% | 5 |
7 | IDIOTYPIC VACCINATION | authKW | 88118 | 1% | 57% | 4 |
8 | IG ALLOTYPE | authKW | 86744 | 0% | 75% | 3 |
9 | LYMPHOMA IMMUNOTHERAPY | authKW | 86744 | 0% | 75% | 3 |
10 | KG JEBSEN INFLUENZA VACCINES | address | 81635 | 1% | 35% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 9426 | 52% | 0% | 412 |
2 | Hematology | 3282 | 20% | 0% | 159 |
3 | Oncology | 1525 | 24% | 0% | 190 |
4 | Medicine, Research & Experimental | 614 | 11% | 0% | 90 |
5 | Biotechnology & Applied Microbiology | 68 | 5% | 0% | 43 |
6 | Cell Biology | 43 | 6% | 0% | 47 |
7 | Biochemical Research Methods | 22 | 3% | 0% | 22 |
8 | Transplantation | 10 | 1% | 0% | 9 |
9 | Genetics & Heredity | 7 | 3% | 0% | 22 |
10 | Cell & Tissue Engineering | 3 | 0% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL THER Y AREA | 137678 | 1% | 36% | 10 |
2 | UNIV NAVARRA HOSP | 115660 | 0% | 100% | 3 |
3 | KG JEBSEN INFLUENZA VACCINES | 81635 | 1% | 35% | 6 |
4 | GEN FLOW CYTOMETRY SERV | 77107 | 0% | 100% | 2 |
5 | UNITE UMR BIOTECHNOL SIGNALISAT CELLULAIRE | 77107 | 0% | 100% | 2 |
6 | UNITE IMMUNOPHYSIOL MOL | 68839 | 1% | 36% | 5 |
7 | KG JEBSEN INFLUENZA VACCINE | 60335 | 1% | 26% | 6 |
8 | EXPT TRANSPLANTAT IMMUNOL | 58735 | 1% | 19% | 8 |
9 | ADULT ONCOLDIS HEMATOL ONCOL | 51403 | 0% | 67% | 2 |
10 | OFF SCI OPERAT | 51403 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF IMMUNOLOGY | 6723 | 6% | 0% | 48 |
2 | JOURNAL OF IMMUNOLOGY | 6178 | 12% | 0% | 93 |
3 | BLOOD | 5444 | 9% | 0% | 70 |
4 | UCLA SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY | 5048 | 1% | 3% | 4 |
5 | JOURNAL OF IMMUNOTHERAPY | 3281 | 2% | 1% | 12 |
6 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 3177 | 2% | 0% | 19 |
7 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 2722 | 3% | 0% | 20 |
8 | CELLULAR IMMUNOLOGY | 1240 | 2% | 0% | 16 |
9 | JOURNAL OF EXPERIMENTAL MEDICINE | 1229 | 3% | 0% | 20 |
10 | BRITISH JOURNAL OF HAEMATOLOGY | 1114 | 3% | 0% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IDIOTYPE | 1182711 | 12% | 33% | 94 | Search IDIOTYPE | Search IDIOTYPE |
2 | IDIOTYPE VACCINATION | 209898 | 1% | 78% | 7 | Search IDIOTYPE+VACCINATION | Search IDIOTYPE+VACCINATION |
3 | IDIOTYPE VACCINE | 183687 | 1% | 53% | 9 | Search IDIOTYPE+VACCINE | Search IDIOTYPE+VACCINE |
4 | RELAY HYPOTHESIS | 107088 | 1% | 56% | 5 | Search RELAY+HYPOTHESIS | Search RELAY+HYPOTHESIS |
5 | IDIOTYPIC VACCINATION | 88118 | 1% | 57% | 4 | Search IDIOTYPIC+VACCINATION | Search IDIOTYPIC+VACCINATION |
6 | IG ALLOTYPE | 86744 | 0% | 75% | 3 | Search IG+ALLOTYPE | Search IG+ALLOTYPE |
7 | LYMPHOMA IMMUNOTHERAPY | 86744 | 0% | 75% | 3 | Search LYMPHOMA+IMMUNOTHERAPY | Search LYMPHOMA+IMMUNOTHERAPY |
8 | ANTI IDIOTYPIC B CELLS | 77107 | 0% | 100% | 2 | Search ANTI+IDIOTYPIC+B+CELLS | Search ANTI+IDIOTYPIC+B+CELLS |
9 | ID KLH | 77107 | 0% | 100% | 2 | Search ID+KLH | Search ID+KLH |
10 | IDIOTYPIC PROTEIN | 77107 | 0% | 100% | 2 | Search IDIOTYPIC+PROTEIN | Search IDIOTYPIC+PROTEIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | INOGES, S , DE CERIO, ALD , SORIA, E , VILLANUEVA, H , PASTOR, F , BENDANDI, M , (2010) IDIOTYPE VACCINES FOR HUMAN B-CELL MALIGNANCIES.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 3. P. 300-307 | 62 | 74% | 8 |
2 | VEELKEN, H , OSTERROTH, F , (2002) VACCINATION STRATEGIES IN THE TREATMENT OF LYMPHOMAS.ONCOLOGY. VOL. 62. ISSUE 3. P. 187 -200 | 74 | 76% | 4 |
3 | BENDANDI, M , (2009) IDIOTYPE VACCINES FOR LYMPHOMA: PROOF-OF-PRINCIPLES AND CLINICAL TRIAL FAILURES.NATURE REVIEWS CANCER. VOL. 9. ISSUE 9. P. 675 -681 | 34 | 85% | 51 |
4 | BOGEN, B , RUFFINI, P , (2009) REVIEW: TO WHAT EXTENT ARE T CELLS TOLERANT TO IMMUNOGLOBULIN VARIABLE REGIONS?.SCANDINAVIAN JOURNAL OF IMMUNOLOGY. VOL. 70. ISSUE 6. P. 526 -530 | 38 | 79% | 14 |
5 | VEELKEN, H , (2003) ACTIVE IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA.SEMINARS IN CANCER BIOLOGY. VOL. 13. ISSUE 3. P. 241-247 | 41 | 77% | 1 |
6 | CORTHAY, A , LUNDIN, KU , MUNTHE, LA , FROYLAND, M , GEDDE-DAHL, T , DEMBIC, Z , BOGEN, B , (2004) IMMUNOTHERAPY IN MULTIPLE MYELOMA: ID-SPECIFIC STRATEGIES SUGGESTED BY STUDIES IN ANIMAL MODELS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 53. ISSUE 9. P. 759-769 | 45 | 66% | 11 |
7 | INOGES, S , DE CERIO, ALD , VILLANUEVA, H , SORIA, E , PASTOR, F , BENDANDI, M , (2011) IDIOTYPE VACCINES FOR LYMPHOMA THERAPY.EXPERT REVIEW OF VACCINES. VOL. 10. ISSUE 6. P. 801-809 | 30 | 75% | 2 |
8 | HOLLANDER, N , (2009) CURRENT VACCINATION STRATEGIES FOR THE TREATMENT OF B-CELL LYMPHOMA AND MULTIPLE MYELOMA.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 29. ISSUE 5. P. 399 -418 | 55 | 42% | 8 |
9 | INOGES, S , DE CERIO, ALD , SAMPOL, A , NIETO, J , SORIA, E , VILLANUEVA, H , PASTOR, F , BENDANDI, M , (2011) STEM CELL TRANSPLANT AND IDIOTYPIC VACCINATION FOR B-CELL MALIGNANCIES.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 11. ISSUE 13. P. 1653-1660 | 28 | 78% | 1 |
10 | BOGEN, B , RUFFINI, PA , CORTHAY, A , FREDRIKSEN, AB , FROYLAND, M , LUNDIN, K , ROSJO, E , THOMPSON, K , MASSAIA, M , (2006) IDIOTYPE-SPECIFIC IMMUNOTHERAPY IN MULTIPLE MYELOMA: SUGGESTIONS FOR FUTURE DIRECTIONS OF RESEARCH.HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. VOL. 91. ISSUE 7. P. 941 -948 | 48 | 48% | 10 |
Classes with closest relation at Level 1 |